• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    CHF Solutions Appoints CEO

    Freehand Partners with Imperial Medial Solutions

    Intersect ENT Announces CMS Approval of Coding Application for Sinus Implant

    Hillrom to Buy Bardy Diagnostics for $375M

    Global Tissue and Organ Transplantation Market to Surpass $25.6 Billion by 2027
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Fixing Face Mask Form and Function

    The Heart of the Matter: Trends in Cardiology

    Virtually the Same? The Challenges of Online Conferences

    Digital Health Delivers During a Year for the Ages

    Advanced Technology for Staking and Swaging Medical Plastics
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Medicoil

    Element

    maxon

    FUTEK Advanced Sensor Technology Inc.

    Creganna Medical, part of TE Connectivity
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Meeting Critical Ventilator Product Requirements Amid Pandemic

    Impact of COVID-19 on the Medtech Supply Chain

    Finding the Upside to a Challenging Year

    Preparing Your Design Controls for FDA Approval

    A 'Trial and Error' Approach to Micromolded Parts
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Element

    Spectrum Plastics Group

    Medicoil

    Creganna Medical, part of TE Connectivity

    FUTEK Advanced Sensor Technology Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    Congress Examines Additional COVID-19 Relief and Recent Regulatory Changes

    The legislative year is nearly coming to a close as Washington survives yet another tumultuous election cycle.

    Related CONTENT
    • Cognito Therapeutics’ Lead Product Receives FDA Breakthrough Device Designation
    • CMS Expedites Breakthrough Device Access; Industry Applauds
    • Unique Contact Lens Sensor System & Manufacturing Process Developed
    • Medtech Matters: Talking Robotic Surgery with Zimmer Biomet
    • CES News: Philips Highlights Healthcare at Home
    Jeffrey J. Kimbell, Eric P. Juhl, JD and David C. Rudloff, Jeffrey J. Kimbell & Associates Inc.11.04.20
    The legislative year is nearly coming to a close as Washington survives yet another tumultuous election cycle. A priority for Congress is passing additional funding for COVID-19 relief to aid businesses, the healthcare industry, and individuals in dealing with the impact of the pandemic. Furthermore, recent regulatory developments highlight approvals by the Centers for Medicare and Medicaid Services (CMS) for New Technology Add-On Payments (NTAP) for Breakthrough Devices.

    State of Additional COVID-19 Relief
    Since the start of the COVID-19 public health emergency (PHE), Congress has passed four pieces of legislation to provide relief to businesses, healthcare providers, and individuals impacted by the pandemic.

    On March 6, President Trump signed into law H.R. 6074, the Coronavirus Preparedness and Response Supplemental Appropriations Act (PL: 116-123), Congress’s first legislative action on the coronavirus. On March 18, President Trump signed into law H.R. 6201, the Families First Coronavirus Response Act (PL: 116-127), Congress’s second round of supplemental funding to fight the coronavirus outbreak. And on March 27, President Trump signed into law H.R. 748, the Coronavirus Aid, Relief, and Economic Security (CARES) Act (PL: 116-136). The $2 trillion CARES Act provides financial support to individuals and businesses affected by the virus, hospitals and healthcare workers, and local communities, as well as funding to develop vaccines and treatments. The fourth piece of legislation, H.R. 266, the Paycheck Protection Program and Health Care Enhancement Act (PL: 116-139), was signed into law on April 24. The $484 billion bill provides supplemental funding to several programs established under the CARES Act.

    The bill increases federal funding to small businesses impacted by COVID-19, providers, and hospitals; it also includes funding to assist state and local governments’ testing capabilities. Specifically, the bill allocates $75 billion to hospitals and healthcare providers to support COVID-19 treatment costs and lost revenues. This funding is in addition to the $100 billion issued to providers under the CARES Act.

    Since passage of the Paycheck Protection Program and Health Care Enhancement Act in April, House Democrats, Senate Republicans, and the White House have engaged in a number of discussions on further COVID-19 relief. Several pieces of legislation have been proposed; however, House Speaker Nancy Pelosi (D-CA), Senate Majority Leader Mitch McConnell (R-KY), and Treasury Secretary Steven Mnuchin have been unable to reach an agreement over the course of nearly six months.

    On May 15, the House passed H.R. 6800, the Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act, in a 208-199 vote, mostly on party lines. The package, which totals over $3 trillion, is House Democrats’ additional legislative proposal to combat the COVID-19 crisis. The package includes funding for state and local governments, healthcare providers, payments to individuals, and further assistance to families in need. Specifically, the bill includes an additional $100 billion for healthcare providers to cover COVID-19- related expenses and lost revenue. McConnell has since refused to take up the bill in the Senate, instead offering his own substantially smaller COVID-19 relief package, the HEALS Act.

    On July 27, Senate Republicans introduced the Health, Economic Assistance, Liability Protection, and Schools (HEALS) Act, a $1 trillion legislative package to provide relief to businesses, workers, healthcare providers, and individuals impacted by the COVID-19 pandemic. The package, which serves as Senate Republicans starting point in negotiations for additional COVID-19 relief, contains liability protections for businesses and employers, a second round of $1,200 payments to individuals earning up to $75,000 and $2,400 for couples earning up to $150,000, and extends enhanced unemployment benefits contained in the CARES Act, while lowering the $600 per week to $200 per week. The bill also provides the U.S. Department of Health and Human Services with $118.4 billion, including $51 billion for COVID-19 testing and vaccine development, and allocates an additional $25 billion to the Provider Relief Fund. Under the bill, providers would have until Jan. 1, 2021, to pay back Medicare Accelerated and Advance payment loans. Further, the bill extends Medicare telehealth waivers through either the length of the public health emergency or Dec. 31, 2021, and provides an additional $190 billion to the Paycheck Protection Program (PPP), allowing entities with less than 300 employees to take out a second PPP loan.

    On Sept. 8, McConnell unveiled a narrower $500 billion COVID-19 relief package. The bill includes $300 billion to bolster weekly unemployment benefits through Dec. 27, and includes another round of loans under the PPP for small businesses. The bill also includes $16 billion for COVID-19 testing and $31 billion for the development of therapeutics and vaccines. Among the larger items not addressed in the bill are assistance to state and local authorities and additional funding for the Provider Relief Fund. On Sept. 10, the bill failed to advance the Senate in a 52-47 vote, needing 60 votes to clear procedural hurdles.

    On Sept. 15, the House Problem Solvers Caucus, a bipartisan group of moderate lawmakers from purple districts, unveiled a $1.52 trillion COVID-19 relief package in an effort to reach a compromise between Democrats and the White House. The package includes $500 billion to state and local governments, $450 per week in enhanced unemployment benefits, stimulus checks to individuals, and an extension of PPP loans for small businesses. The bill also extends liability protections for businesses and employers, and includes $30 billion to support healthcare providers and $45 billion in forgiveness of Medicare loans to providers. Notably, Pelosi did not offer support for the package, stating her intent to hold out for something with a much larger price tag. President Donald Trump had signaled openness to the Problem Solvers proposal, calling on Senate Republicans to support a larger sized package.

    On Oct. 1, the House passed H.R. 925, the Heroes Act, on a 214-207 vote. The $2.2 trillion bill, which is a smaller version of the HEROES Act, includes another round of $1,200 stimulus checks to individuals, $600 per week in enhanced unemployment benefits, $436 billion to state and local governments, and allows the hardest hit small businesses to apply for additional PPP loans. The bill also includes $75 billion for coronavirus testing and contact tracing and provides $20 billion to the Biomedical Advanced Research and Development Authority (BARDA) for the development and procurement of vaccines and therapeutics. McConnell has since indicated he would not take up the bill in the Senate.

    As of the time of writing, Congress is still working on the details of an additional COVID-19 relief package, as negotiations between the House, Senate, and White House continue. These efforts have been sidelined by campaigning and the political dynamics surrounding the elections on Nov. 3, in addition to commentary from the president. On Oct. 6, President Trump abruptly directed his representatives in the White House to stop negotiating with House Democrats on an additional COVID-19 relief package until after the election, during the lame-duck session. However, in an about-face on Oct. 8, the President called on Congress to pass a large COVID-19 relief package. Before the election, Senate Republicans plan to examine another relief package, however, as of this writing, a clear path to its passage is unclear.

    Members of both parties agree more needs to be done, but there are substantial differences on the timing and substance of such legislative action. There is now the expectation that Congress will examine additional COVID-19 relief during the lame-duck session, which lasts from Nov. 3 to the start of the new Congress on Jan. 3, 2021.

    Regulatory Updates
    This summer, CMS devoted much of its energy to drafting and releasing a number of proposed rules related to the Medicare program, including payment rules for both the inpatient and outpatient settings, the Medicare physician fee schedule proposed rule, and the Medicare Coverage of Innovative Technology proposed rule designed to provide faster access to new, innovative medical devices that have been designated as “breakthrough” by the U.S. Food and Drug Administration (FDA) and have also received market authorization. Now is the time to start watching for the release of the final versions of these rules.

    The first of these final rules was issued on Sept. 2 with the release of the “Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System and Final Policy Changes and Fiscal Year 2021 Rates” (IPPS) Final rule, which updates the national standardized amount for inpatient hospital operating costs for FY 2021. Among other provisions, the 2021 IPPS approved 13 technologies that applied for new technology add-on payments for FY 2021, including two technologies under the alternative pathway for new medical devices that are part of the FDA Breakthrough Devices Program (BDP).

    The BDP was established in 2016 and is a voluntary program for certain medical devices that provide for more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions. Per the FDA, the goal of the BDP is to “provide patients and health care providers with timely access to these medical devices by speeding up their development, assessment, and review, while preserving the statutory standards for premarket approval, 510(k) clearance, and De Novo marketing authorization, consistent with the Agency’s mission to protect and promote public health.”

    To obtain a breakthrough device designation, the device must meet a set of multipronged criteria. First, the device must provide for more effective treatment or diagnosis of life-threatening or irreversibly debilitating disease or conditions. Second, a device must either represent a breakthrough technology, have no approved or cleared alternatives, offer significant advantages over existing approved or cleared alternatives, or be determined that its availability is in the best interest of patients. To date, the FDA has granted nearly 300 breakthrough device designations.

    FY 2021 is the first year for which CMS received applications under the alternative new technology add-on payment model for breakthrough devices—a process CMS finalized in the FY 2020 IPPS rule. In creating the pathway, CMS stated, “[t]his will provide additional Medicare payment for these technologies while real-world evidence is emerging, giving Medicare beneficiaries timely access to the latest innovations in treatment.” It will be interesting to see how many additional devices take advantage of this new pathway in years to come. 


    Jeffrey J. Kimbell, president and founder of Jeffrey J. Kimbell & Associates Inc., represents 45 clients in the life sciences community seeking legislative and policy remedies in Washington. Founded in 1998, the firm provides strategic solutions to clients seeking creation, modification, or proper implementation of public law.

    Eric P. Juhl is a senior director of health policy and reimbursement strategy at Jeffrey J. Kimbell & Associates Inc.

    David C. Rudloff is a senior manager of government affairs at Jeffrey J. Kimbell & Associates Inc. 
    Suggested For You
    Medtech Matters: Medtronic Medtech Matters: Medtronic's Robotic Surgery Status
    Cognito Therapeutics’ Lead Product Receives FDA Breakthrough Device Designation Cognito Therapeutics’ Lead Product Receives FDA Breakthrough Device Designation
    CMS Expedites Breakthrough Device Access; Industry Applauds CMS Expedites Breakthrough Device Access; Industry Applauds
    Unique Contact Lens Sensor System & Manufacturing Process Developed Unique Contact Lens Sensor System & Manufacturing Process Developed
    Medtech Matters: Talking Robotic Surgery with Zimmer Biomet Medtech Matters: Talking Robotic Surgery with Zimmer Biomet
    CES News: Philips Highlights Healthcare at Home CES News: Philips Highlights Healthcare at Home
    Olympus and Hitachi Sign Five-Year Contract Olympus and Hitachi Sign Five-Year Contract
    Acutus Medical Launches AcQCross Transseptal System in Europe Acutus Medical Launches AcQCross Transseptal System in Europe
    Study Shows Lungpacer System Improves Diaphragm Strength by More Than 300 Percent Study Shows Lungpacer System Improves Diaphragm Strength by More Than 300 Percent
    Solvay Partners With PrinterPrezz on 3D Printing for Medical Devices Solvay Partners With PrinterPrezz on 3D Printing for Medical Devices
    New Clinical Trial Data Supports BD Libertas Wearable Injector as a Drug Delivery System New Clinical Trial Data Supports BD Libertas Wearable Injector as a Drug Delivery System
    Quantitative Transmission Ultrasound Outperforms Mammography Quantitative Transmission Ultrasound Outperforms Mammography
    BioSerenity Achieves FDA Clearance for Wearable Device System BioSerenity Achieves FDA Clearance for Wearable Device System
    Greenlight Guru and Nelson Labs Partner Greenlight Guru and Nelson Labs Partner
    Olympus Releases ScopeLocker Endoscope Storage Cabinet Olympus Releases ScopeLocker Endoscope Storage Cabinet

    Related Columns

    • Fixing Face Mask Form and Function

      Fixing Face Mask Form and Function

      Masks for the general public are varied in both style and effectiveness.
      Sam Brusco, Associate Editor 11.04.20

    • Cardiovascular
      The Heart of the Matter: Trends in Cardiology

      The Heart of the Matter: Trends in Cardiology

      Of the three major segments of coronary stents, bioabsorbable stents are expected to have the highest growth between now and 2022.
      Maria Shepherd, President and Founder, Medi-Vantage 11.04.20

    • Virtually the Same? The Challenges of Online Conferences

      Virtually the Same? The Challenges of Online Conferences

      Like everyone else on the planet, I’m turning increasingly to virtual solutions to our physical challenges in the midst of a pandemic.
      Dawn A. Lissy, Founder & President, Empirical 11.04.20


    • Digital Health
      Digital Health Delivers During a Year for the Ages

      Digital Health Delivers During a Year for the Ages

      Internet of Medical Things technologies have emerged as the key enabler of a much more holistic and complete disease-state management toolbox.
      Brad Womble, Senior Director of Strategy, Marketing, and Mergers & Acquisitions, Jabil Healthcare 11.04.20

    • Advanced Technology for Staking and Swaging Medical Plastics

      Advanced Technology for Staking and Swaging Medical Plastics

      It reliably assembles heat- and vibration-sensitive components, and works with a wide range of plastic materials.
      Priyank Kishor, Global Product Manager—PulseStaking, Branson at Emerson 11.04.20

    • Quality Assurance When Supply Chain Disruptions Arise

      Quality Assurance When Supply Chain Disruptions Arise

      From supply chain disruptions to impromptu manufacturing modifications, the medical device industry has faced a whirlwind of complications in 2020.
      Sandi Schaible and Peter Steen, WuXi AppTec Medical Device Testing 11.04.20


    • The Top 30 and M&A in 2021: What’s Next?

      The Top 30 and M&A in 2021: What’s Next?

      With three of the top five companies appointing new CEOs in the last year and the global pandemic eroding earnings, M&A strategies could look a lot different.
      Florence Joffroy-Black and Dave Sheppard, MedWorld Advisors 11.04.20

    • COVID 19: Supply Chain Professionals’ Ultimate Reality Challenge

      COVID 19: Supply Chain Professionals’ Ultimate Reality Challenge

      Having been a part of the medtech supply chain for 40 years, I can say there has never been a more difficult time for supply chain professionals.
      Chris Oleksy, Founder and CEO, Oleksy Enterprises and Next Life Medical; CEO, Emergent Respiratory 11.04.20

    • 3D/Additive Manufacturing
      Additive Manufacturing: Debinding Fluids Must-Haves

      Additive Manufacturing: Debinding Fluids Must-Haves

      As the pressure to produce more complex biomedical parts increases, medical device manufacturing using 3D printing is gaining widespread acceptance.
      Venesia Hurtubise, Technical Chemist, MicroCare Medical 11.04.20


    • Diagnostics
       How COVID-19 is Reshaping the Diagnostics Testing Sector

      How COVID-19 is Reshaping the Diagnostics Testing Sector

      The short-term impact on the diagnostics sector is readily apparent as the pandemic has fueled overwhelming demand for effective SARS-CoV-2 testing solutions.
      Eric Williams, Managing Director, Capstone Headwaters 11.04.20

    • Will Industry’s COVID-19 Recovery End Prematurely?

      Will Industry’s COVID-19 Recovery End Prematurely?

      Finally, a light at the end of the tunnel, but will it remain lit?
      Michael Barbella, Managing Editor 10.01.20

    • Surgical
      Hype or Hope? The Future of Surgical Robotics

      Hype or Hope? The Future of Surgical Robotics

      Recent publications suggest the U.S. performs more robotic surgery than every other country in the world.
      Maria Shepherd, President and Founder, Medi-Vantage 10.01.20


    • COVID Community: How the Pandemic Is Bringing Out the Best in Us

      COVID Community: How the Pandemic Is Bringing Out the Best in Us

      Given the brain power and generosity of our industry, I knew I could follow the wisdom of Fred Rogers’ mother and “look for the helpers.”
      Dawn A. Lissy, Founder & President, Empirical 10.01.20

    • Electronics
      Why Applying Cleanliness Standards to Outsourced Medical Electronics Is Important

      Why Applying Cleanliness Standards to Outsourced Medical Electronics Is Important

      When looking to outsource the manufacture of electronic medical devices, cleanliness standards and processes should be a top consideration.
      Jay Tourigny, Senior Vice President, MicroCare Medical 10.01.20

    • The Current COVID-19 Environment and Emergency Use Authorizations

      The Current COVID-19 Environment and Emergency Use Authorizations

      This column will provide information related to FDA EUAs granted due to the global COVID-19 pandemic.
      Christine Scifert and Dawn Norman, M.S., MRC-X LLC 10.01.20


    Trending
    • Philips Buys Capsule Technologies In $635M Deal
    • Cytotron Gains Breakthrough Status To Treat Breast, Liver, And Pancreatic Cancers
    • Top 10 Trends In The Medical Device And Equipment Industry
    • 5 Ways Plastics Revolutionized The Healthcare Industry
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    Breaking News
    • CHF Solutions Appoints CEO
    • Freehand Partners with Imperial Medial Solutions
    • Intersect ENT Announces CMS Approval of Coding Application for Sinus Implant
    • Hillrom to Buy Bardy Diagnostics for $375M
    • Global Tissue and Organ Transplantation Market to Surpass $25.6 Billion by 2027
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Pharmaceutical Focus: A Look at Combination Products
    • The Printed World: Additive Manufacturing in Medtech
    • The Lost Year: 2020 Year in Review
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    BGG Obtains U.S. Patent on AstaZine Natural Astaxanthin for Heart Function During Exercise
    Qualitas Health/iwi Raises $10 Million in Investment Round
    Aker BioMarine Expands Krill Portfolio with Novel Protein Hydrolysate
    Coatings World

    Latest Breaking News From Coatings World

    IGL Coatings Launches Graphene Reinforced Dual System Ceramic Coating
    Miller Paint Declares Simple Serenity its 2021 Color of the Year
    TAUBMANS Paint by PPG Releases ‘Chromatic Joy’ Palettes
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    CHF Solutions Appoints CEO
    Freehand Partners with Imperial Medial Solutions
    Intersect ENT Announces CMS Approval of Coding Application for Sinus Implant
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Bone Therapeutics, Rigenerand Ink Cell Therapy Deal
    NovaQuest Private Equity Acquires CoreRx
    JS Bio and Etta Biotech Advancing Partnership
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Marino Belotti Presents New Website
    Essence Cosmetics Expands in the U.S.
    Sigma Beauty Launches 'Brush Care' Sets at Sephora
    Happi

    Latest Breaking News From Happi

    Mix:Bar Launches at Target
    Crystal Deodorant Unveils Magnesium-Enriched Sticks
    Euromonitor Reveals Top 10 Global Consumer Trends for 2021
    Ink World

    Latest Breaking News From Ink World

    Cowan Graphics Adds Fujifilm Inca OnsetX3 HS
    Packaging Printing Market Worth $433.4 Billion by 2025: MarketsandMarkets
    O-I Foundation Gifts $50k to Facilitate COVID-19 Vaccine Access
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Domino grows installation and service teams
    ABG keeps pace with demand with recruitment drive
    Acucote expands FSC-certified portfolio
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Honeywell Delivered 225 Million Masks in December
    Techtextil, Texprocess Postponed to 2022
    Super Strong Inks Survive Tough Environments
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Bioventus Appoints SVP of Operations
    DePuy Synthes Receives 510(k) FDA Clearance for VELYS Robotic-Assisted Solution
    OrthoPediatrics Expands Agent Network in Three European Countries
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    UDC Subsidiary Adesis' Website Wins 2020 MarCom Platinum Award
    Roadsimple Modernizes Warehouse Ops with Zebra Technologies
    Graphene Flagship Launches Redesigned Website

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login